Drug Shortage Report for TARO-TESTOSTERONE CYPIONATE INJECTION

Last updated on 2025-05-01 History
Report ID 242561
Drug Identification Number 02496003
Brand name TARO-TESTOSTERONE CYPIONATE INJECTION
Common or Proper name Testosterone
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) TESTOSTERONE CYPIONATE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10 mL
ATC code G03BA
ATC description ANDROGENS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-11-01
Estimated end date 2025-06-27
Actual end date
Shortage status Actual shortage
Updated date 2025-05-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2025-05-01 French Compare
v15 2025-05-01 English Compare
v14 2025-04-24 French Compare
v13 2025-04-24 English Compare
v12 2025-04-04 French Compare
v11 2025-04-04 English Compare
v10 2025-02-21 French Compare
v9 2025-02-21 English Compare
v8 2025-02-10 French Compare
v7 2025-02-10 English Compare
v6 2025-01-28 French Compare
v5 2025-01-28 English Compare
v4 2025-01-07 French Compare
v3 2025-01-07 English Compare
v2 2024-11-11 French Compare
v1 2024-11-11 English Compare

Showing 1 to 16 of 16